Centric Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$462K Buy
+640
New +$380K 0.07% 149
2023
Q4
– Sell
-648
Closed -$328K – 164
2023
Q3
$328K Hold
648
– – 0.14% 84
2023
Q2
$335K Buy
648
+270
+71% +$146K 0.13% 85
2023
Q1
$218K Hold
378
– – 0.09% 96
2022
Q4
$208K Sell
378
-44
-10% -$23.3K 0.11% 95
2022
Q3
$214K Sell
422
-11
-3% -$6.16K 0.09% 111
2022
Q2
$235K Buy
433
+9
+2% +$4.95K 0.09% 115
2022
Q1
$251K Buy
424
+29
+7% +$16.7K 0.08% 137
2021
Q4
$264K Sell
395
-14
-3% -$8.74K 0.09% 131
2021
Q3
$234K Hold
409
– – 0.09% 139
2021
Q2
$206K Buy
+409
New +$193K 0.07% 144

Other funds holding TMO

Centric Wealth Management's TMO Position: Q3 2026 in Review

Centric Wealth Management opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 640 shares worth $462K. The stake represents 0.07% of the portfolio and ranks #149 among its holdings. This is a return to the name: Centric Wealth Management previously reported a position in TMO as recently as Q3 2023.

Centric Wealth Management first reported a position in TMO in Q2 2021 and has held it in 11 quarters since. 2,450 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Centric Wealth Management held 640 shares of Thermo Fisher Scientific worth $462K as of Q3 2026.
  • Thermo Fisher Scientific was a new Centric Wealth Management position in Q3 2026.
  • Thermo Fisher Scientific made up 0.07% of Centric Wealth Management's portfolio in Q3 2026, its #149 holding.
  • Centric Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 11 quarters since.
  • 2,450 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Centric Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.